How to Finance a Medical Equipment Supplier Acquisition

From SBA 7(a) loans to seller notes, understand the capital structures buyers use to acquire DMEPOS and DME businesses in the $1M–$5M revenue range.

Find Medical Equipment Supplier Deals SBA Calculator →

Acquiring a medical equipment supplier requires capital structures that account for regulatory complexity, recurring rental revenue, and reimbursement risk. Most lower middle market DME deals combine SBA financing with seller notes or equity rollovers to bridge valuation gaps and align post-close incentives around compliance and contract retention.

Financing Options for Medical Equipment Supplier Acquisitions

SBA 7(a) Loan

$1M–$5MPrime + 2.25%–2.75% (variable); currently ~10–11%

The most common financing tool for DME acquisitions. SBA 7(a) loans cover up to $5M, making them ideal for DMEPOS businesses with clean Medicare billing histories, active accreditations, and demonstrable recurring revenue from rentals and service contracts.

Pros

Low equity injection requirement of 10–20%, preserving buyer liquidity for working capital and inventory refresh post-close
Lenders familiar with healthcare businesses accept DMEPOS accreditation and Medicare provider numbers as intangible collateral
10-year terms reduce monthly debt service, supporting DSCR requirements even with reimbursement rate variability

Cons

×SBA lenders scrutinize Medicare/Medicaid audit exposure and billing compliance history, potentially slowing approval for flagged businesses
×Personal guarantee required, creating full recourse exposure for the buyer against all business and personal assets
×Prepayment penalties apply in the first three years, limiting refinancing flexibility if reimbursement rates compress margins

Seller Financing (Seller Note)

$100K–$750K (5–15% of purchase price)6%–8% fixed, interest-only for 12–24 months common

Sellers in DME transactions frequently carry 5–15% of the purchase price as a subordinated note, bridging valuation gaps and demonstrating confidence in post-close reimbursement continuity and supplier contract transferability.

Pros

Reduces buyer equity injection requirement and signals seller confidence in business quality and regulatory standing post-transition
Flexible terms allow deferral of principal payments during the critical post-close transition of referral relationships and billing operations
Aligns seller incentive to support Medicare provider number transfer and supplier agreement continuity through the note period

Cons

×SBA rules require seller notes to be on full standby for 24 months, meaning no payments to seller during that period
×Seller may demand higher overall purchase price to offset the risk and illiquidity of carrying subordinated debt post-close
×Relationship tension can arise if post-close reimbursement declines or supplier agreements lapse, straining note repayment

Equity Rollover (Partial Seller Equity Retention)

10–20% of total deal equity valueN/A — equity stake; seller participates in future upside

Strategic and PE-backed acquirers often structure DME deals with the seller retaining a 10–20% equity stake, supporting regulatory continuity, referral relationship retention, and DMEPOS accreditation transfer during the transition period.

Pros

Keeps the seller financially engaged post-close, protecting referral networks and Medicare billing continuity during the transition period
Reduces upfront cash required from buyer, lowering equity injection and improving first-year cash-on-cash return metrics
Aligns seller with post-close performance, reducing risk of customer and referral source attrition after ownership transfer

Cons

×Shared ownership post-close can create governance friction, especially if reimbursement changes or supplier issues emerge
×Seller may resist full operational handover while retaining equity, slowing buyer's ability to implement systems and cost improvements
×Valuing the rollover stake requires agreement on forward EBITDA assumptions, creating negotiation complexity in uncertain reimbursement environments

Sample Capital Stack

$2.5M (acquisition of a DMEPOS supplier at 5x $500K EBITDA)

Purchase Price

~$22,000/month on SBA loan at 10.75% over 10 years

Monthly Service

Approximately 1.35x DSCR based on $500K EBITDA and $264K annual SBA debt service — within acceptable SBA lender range

DSCR

SBA 7(a) loan: $2.0M (80%) | Seller note on standby: $250K (10%) | Buyer equity injection: $250K (10%)

Model your own deal structure →

Lender Tips for Medical Equipment Supplier Acquisitions

1Lead with recurring revenue documentation: show lenders the proportion of EBITDA derived from rental income and service contracts versus one-time equipment sales — recurring revenue significantly improves SBA credit approval odds.
2Present a clean compliance file upfront, including DMEPOS accreditation certificates, Medicare/Medicaid provider numbers, and a summary of any prior audits or overpayment resolutions — lenders will request these regardless.
3Demonstrate customer diversification clearly: if any single hospital system or physician group exceeds 20% of revenue, proactively address the concentration risk with documented referral source depth and relationship history.
4Engage an SBA lender with healthcare deal experience before signing an LOI — lenders familiar with DME billing structures and reimbursement mechanics will move faster and create fewer conditions precedent at closing.

Frequently Asked Questions

Can I use an SBA 7(a) loan to acquire a Medicare-accredited DME business?

Yes. SBA 7(a) loans are well-suited for DMEPOS acquisitions. Lenders will verify active accreditation, clean billing history, and transferable Medicare provider numbers as part of underwriting — prepare these documents early.

How does reimbursement risk affect lender appetite for DME acquisitions?

Lenders assess CMS reimbursement exposure carefully. Businesses with diversified payer mix, limited competitive bidding exposure, and strong private-pay or rental revenue are viewed more favorably than those with Medicare-heavy, single-product revenue streams.

Will a seller note count toward my SBA equity injection requirement?

No. SBA guidelines require seller notes to be on full standby for 24 months and do not count toward the buyer's equity injection. You must inject at least 10% in unencumbered cash or eligible equity to satisfy SBA requirements.

What EBITDA threshold does a DME business need to qualify for SBA financing?

Most SBA lenders require a minimum of $300K–$500K in adjusted EBITDA with a DSCR of at least 1.25x after debt service. Recurring rental and service contract revenue is weighted positively in healthcare business underwriting.

More Medical Equipment Supplier Guides

Buy a Medical Equipment Supplier Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Medical Equipment Supplier acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required